关注
Kendra Kumar Shrestha
Kendra Kumar Shrestha
Department of Chemistry and Biochemistry, The University of Toledo, Ohio, USA
在 rockets.utoledo.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Regioselective α-Deuteration of Michael Acceptors Mediated by Isopropylamine in D2O/AcOD
VG Landge, KK Shrestha, AJ Grant, MC Young
Organic Letters 22 (24), 9745-9750, 2020
162020
Oxidative Mizoroki–Heck reaction of unprotected cinnamylamines at ambient temperature under air
ON Farinde, V Satheesh, KK Shrestha, CR Rhinehalt, VG Landge, ...
Organic Chemistry Frontiers 10 (16), 3982-3988, 2023
22023
Optical Control of Cell-Surface and Endomembrane-Exclusive β-Adrenergic Receptor Signaling
W Thotamune, S Ubeysinghe, KK Shrestha, ME Mostafa, MC Young, ...
Journal of Biological Chemistry, 107481, 2024
12024
Self‐Supported Heterogeneous Dirhodium (II) Catalyst for Nitrene and Carbene Transfer Reactions
V Satheesh, I Alahakoon, KK Shrestha, LC Iheme, M Marszewski, ...
European Journal of Organic Chemistry 27 (8), e202301114, 2024
12024
Combining iminium and supramolecular catalysis for the [4+ 2] cycloaddition of E-cinnamaldehydes
KK Shrestha, MA Hilyard, I Alahakoon, MC Young
Organic & biomolecular chemistry 20 (33), 6646-6653, 2022
12022
Controlling Solvent Effects on in situ Pd Nanoparticle Synthesis Allows ß-Selective Heck Reactions of Unprotected Cinnamylamines
KK Shrestha, ON Farinde, AM Gohmann, R Kondapalli, V Satheesh, ...
2024
Abstract 1248 A photosensitive Isoproterenol (OptoIso) delivers spatiotemporally precise cell surface and endomembrane-exclusive beta-adrenergic receptor signaling
W Thotamune, S Ubeysinghe, K Shrestha, M Mostafa, J Edwards, ...
Journal of Biological Chemistry 300 (3), 2024
2024
Self-Supported Heterogeneous Dirhodium (II) Catalyst for Nitrene and Carbene Transfer Reactions
M Young, V Satheesh, I Alahakoon, K Shrestha, L Iheme, M Marszewski
2023
A novel UVA-labile β-adrenergic agonist allows for optical control of subcellular signaling
W Thotamune, S Ubeysinghe, A Karunarathne, KK Shrestha, MC Young, ...
Journal of Pharmacology and Experimental Therapeutics 385 (S3), 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–9